InvestorsHub Logo
Followers 58
Posts 10086
Boards Moderated 1
Alias Born 09/21/2016

Re: Talon38 post# 116647

Wednesday, 08/23/2017 7:12:28 AM

Wednesday, August 23, 2017 7:12:28 AM

Post# of 459821
T-38 right on..

Take another look at the Biogen Lab video, especially where Dr Sandrock talks about going for the cure and applying what is learned from M/S to other neurodegenerative diseases.

-----

Remyelination....Think what a drug that actually repairs nerve sheaths rather than just treating the disease symptoms would do to the M/S treatment world? It is the "Holy Grail".....Biogen knows this and its lab manager's, Drs Sandrock, Rudick, Ransohoff and Henderson have stated that in the Biogen Lab clip below, and ANAVEX knows it. Some of the other BPs may soon know what we have and will comprehend what a simple safe tablet form of 2-73 will due to M/S treatment cost. Last but most importantly the FDA and Congress will see a much more effective and cheaper drug to stop the spiraling costs of M/S disease.
-------

https://www.biogen.com/en_us/about-biogen/multiple-sclerosis/leading_a-path-forward.leading-way-ms.html




These polarized dynamics are massive. If you imagine a barrier with a strong vertical line defining the interface between two bodies. On one side are giant +++++ (pluses, which represent knowledge and information) and the other side of the barrier represents need for information and knowledge with massive ----- minus charges (representing need for information). There is certain to be some minor LEAKAGE across that barrier from + to -, the information will leak, then flow, then suddenly avalanche conditions will occur. We may not even know what happened to trigger it. The strong bias variable is $$$, lots of $$$ at stake, depending on when the first leaks start. In this model the breakdown/avalanche condition point is unknown but it has some $$$$$ value which IMO will be reached before the Sept 11 session. Sweet.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News